We believe transparency is an important part of our ongoing collaboration with the health care community, helping to build a community of trust and respect with healthcare professionals, patients, industry peers, stockholders and the public.
EFPIA
Biogen strongly believes that collaboration with Healthcare Professionals and Healthcare Organisations is crucial to discover, develop and deliver innovative therapies that improve the lives of patients. At the same time, we believe that these interactions must be conducted openly and transparently.
As a member of EFPIA (the European Federation of Pharmaceutical Industries and Associations) and the ABPI (Association of the British Pharmaceutical Industry), Biogen is proud to endorse and uphold the EFPIA Disclosure Code and the ABPI Code of Practice disclosure requirements. In line with the codes, Biogen has been collecting all payments and contributions made to HCPs and HCOs since January 2015.
These payments are published on Disclosure UK, the ABPI's disclosure database, on their website.
Biogen-17187 Date of Preparation: June 2019
Patient Organisation Support
Biogen is proud to work with Patient Organisations and support their efforts to improve the lives of their members and raise awareness of serious medical conditions. We are aligned in enhancing patient advocacy and supporting medical research for the discovery of effective therapies. Below is a breakdown of the support Biogen has provided to Patient Organisations in the UK.
2018
In 2018 Biogen contributed £318,636.88 to UK Patient Organisations.
| Patient organisation | Project | Amount of support |
|---|---|---|
| MS Society | Sponsorship - MS Society Awards 2018 | £8,500.00 |
| MS Trust | Speaker Fee - Non-Medical Prescriber Education Meeting January 2018 | £906.40 |
| MS Trust | Grant - Funding towards Specialist Nurse Programme | £85,000.00 |
| MS Trust | Speaker Fee - December 2017 Meeting | £600.00 |
| MS Trust | Sponsorship - MS Trust Annual Conference November 2018 | £25,000.00 |
| MS Trust | Speaker Fee - MS Nurse Advisory Board Meeting September 2018 | £552.50 |
| MS Trust | Speaker Fee - Scottish MS Specialist Nurse Academy September 2018 | £439.00 |
| MS Trust | Sponsorship - MS Trust Annual Conference November 2018 | £1,500.00 |
| Muscular Dystrophy UK | Sponsorship - Neuromuscular Translational Research Conference 2018 | £6,000.00 |
| Muscular Dystrophy UK | Sponsorship - Neuromuscular Physiotherapy Conference June 2018 | £1,000.00 |
| The Neurological Alliance | Industry Reference Group 2018 | £10,310.00 |
| Revive MS Support | Grant - Funding towards film editing | £40,000.00 |
| Revive MS Support | Grant - Funding towards Physiotherapy Service | £60,000.00 |
| SHIFT MS | Grant - Funding towards Volunteer Network | £15,000.00 |
| SHIFT MS | Speaker Fee - February 2018 | £348.75 |
| SHIFT MS | Grant - Animated Symptoms | £18,480.23 |
| SHIFT MS | Sponsorship - MS Supporter Series Collaboration | £25,000.00 |
| Spinal Muscular Atrophy Support UK | Grant - Funding towards SMA Family Conference April 2018 | £20,000.00 |
Biogen-17187 Date of Preparation: June 2019
HCP Support
Biogen strongly believes that collaboration with Healthcare Professionals is crucial to discover, develop and deliver innovative therapies that improve the lives of patients. At the core of this relationship is the ability to share knowledge in order to improve patient outcomes. At the same time, we believe that Biogen’s interactions with HCPs must be conducted openly and transparently, as embodied by the principles of the EFPIA Disclosure Code and the ABPI Code of Practice.
To this end, Biogen supports the decision to publically disclose the payments and contributions made to HCPs. By committing ourselves to the highest standards of integrity and accountability, we look to lead our industry in building trust with the communities we serve.
Payments made from 2015 onwards are published on Disclosure UK, the ABPI's disclosure database, on their website.
Biogen-17187 Date of Preparation: June 2019